On the Frontlines of Psoriasis

ReachMD
  • 0.0 (0)
  • SCIENCE

Stay up to date on the latest advancements in the management of one of the most common types of skin diseases with our exclusive podcast series, On the Frontlines of Psoriasis. Tune in to hear from leading dermatology experts as they explore key diagnosis and treatment strategies in addition to the ongoing research that’s reshaping our understanding of this common and chronic disease.

  1. JAN 16

    Unlocking the Potential of TYK2 Inhibitors in Plaque Psoriasis

    Guest: Christopher Bunick, MD, PhD, FAAD Host: Ryan Quigley With high selectivity, durable response, and once-daily dosing, next-generation TYK2 inhibitors offer a promising oral option for patients with moderate-to-severe plaque psoriasis. Ryan Quigley sits down with Dr. Christopher Bunick, Associate Professor of Dermatology and Translational Biomedicine at Yale University School of Medicine, to learn more about how these agents may align with evolving patient preferences and expand options beyond injectables.

    15 min

  2. 12/31/2025

    Dietary Guidance in Psoriasis: Evidence-Based Supportive Strategies

    Guest: Peter Lio, MD Host: Ryan Quigley Flare patterns, patient concerns, and growing research have brought diet to the forefront of psoriasis care. Tune in as Dr. Peter Lio reviews the strongest evidence behind weight management, gluten sensitivity, and anti-inflammatory nutrition, offering clarity on how diet can support—though not replace—primary treatments. Dr. Lio is a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a dermatologist at Medical Dermatology Associates of Chicago.

    11 min

  3. 12/31/2025

    Preparing for Parenthood in Psoriasis: Closing Gaps in Family Planning Support

    New research highlights what patients with psoriasis really want to know about family planning and pregnancy—and when they want to hear it. Discover how proactively addressing these topics can close communication gaps, improve outcomes, and empower patients during this critical life stage with host Ryan Quigley and Ms. Liana Barenbrug, a PhD candidate at Radboud University Medical Center in the Netherlands.

    9 min

  4. 12/31/2025

    Shifting the Script: How Inner Dialogue Influences Psoriasis Progress

    Host: Ryan Quigley Guest: Michael Greenberg, MD A patient’s inner dialogue—especially negative self-talk—can influence their perception of disease, adherence to treatment, and emotional wellbeing. Ryan Quigley sits down with Dr. Michael Greenberg, a dermatologist at the Illinois Dermatology Institute, as he shares observations from his own practice, highlighting how recognizing subtle emotional cues and practicing empathetic communication can help support more holistic and sustainable outcomes in psoriasis.

    9 min

  5. 07/23/2025

    Genetics in Psoriasis: Impacts on Risk, Comorbidities, and Care

    Guest: Audrey Bui, DO Genetic insights are reshaping how we understand the development and comorbidities of psoriasis, as well as treatment response in patients. Hear Dr. Audrey Bui discuss how genetic variants influence risks for certain conditions, how they may predict response to therapies like methotrexate, ustekinumab, and IL-17 inhibitors, and how integrating genetic markers into clinical care can enable more targeted, effective psoriasis management. Dr. Bui is a recent graduate from Lake Erie College of Osteopathic Medicine and an intern at the University of Central Florida prior to starting her dermatology residency at Hackensack Meridian Health Palisades Medical Center.

    4 min

  6. 06/10/2025

    Skin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection

    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Joel M. Gelfand, MD, MSCE, FAAD Guest: Michael S. Garshick, MD Inflammatory skin diseases like psoriasis don’t just affect the skin—they can often reflect broader cardiovascular risks. Given the overlap between dermatology and cardiology, knowing how to spot warning signs early and what steps to take during routine visits is key to comprehensive care. Joining Dr. Mary Cheeley to discuss the connection between the skin and the heart are Drs. Joel Gelfand and Michael Garshick. Dr. Gelfand is a dermatologist at the University of Pennsylvania and the Director of the Psoriasis and Phototherapy Treatment Center and the Center for Clinical Sciences in Dermatology. Dr. Garshick is a cardiologist and the Director of the Cardio-Rheumatology Program at NYU Langone Health, as well as an Assistant Professor of Medicine and Dermatology at NYU Grossman School of Medicine.

    12 min

  7. 06/03/2025

    Comparing Home and Office-Based UVB Phototherapy: Insights from the LITE Study

    Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joel M. Gelfand, MD, MSCE, FAAD Guest: Valerie Harrison, PhD Home-based narrowband UVB phototherapy may offer a more accessible and effective option for managing psoriasis, as shown by the results of a recent study. With benefits like improved adherence, lower costs, and greater accessibility, this approach offers a compelling alternative for patients managing chronic disease. Explore the implications of this research and how it could shape future clinical practice with Dr. Joel Gelfand and Valerie Harrison. Dr. Gelfand is the Director of the Psoriasis and Phototherapy Treatment Center and the Center for Clinical Sciences in Dermatology at the University of Pennsylvania, as well as the lead investigator of the LITE study. Valerie Harrison is a study participant and a member of the National Psoriasis Foundation’s Board of Directors.

    12 min

  8. 05/14/2025

    Examining Psoriasis Prevalence: Diagnostic Differences Across Demographics

    Guest: Joe K. Tung, MD, MBA Psoriasis affects nearly eight million adults in the US, but its impact isn’t felt equally; significant disparities in diagnosis exist across race, ethnicity, and socioeconomic status. Join Dr. Joe Tung as he discusses his recent analysis of data from the National Health Interview Survey, in which he explored the most affected patient populations, the potential for underdiagnosis, and the broader ties between psoriasis, metabolic health, and life satisfaction. Dr. Tung is a board-certified dermatologist currently serving as the Medical Director of UPMC Falk Dermatology, Director of the Clinical Trials Unit, and Associate Director of the Dermatology Residency Program.

    5 min
See All (24)

About

Stay up to date on the latest advancements in the management of one of the most common types of skin diseases with our exclusive podcast series, On the Frontlines of Psoriasis. Tune in to hear from leading dermatology experts as they explore key diagnosis and treatment strategies in addition to the ongoing research that’s reshaping our understanding of this common and chronic disease.

Information

  • Creator
    ReachMD
  • Years Active
    2024 - 2026
  • Episodes
    24
  • Rating
    Clean
  • Copyright
    © Copyright 2026 ReachMD. All rights reserved.
  • Show Website
    On the Frontlines of Psoriasis